Adlai Nortye Ltd (ANL) Stock Price, Quote, News & History

ANLNASDAQ
$10.30
0.252.49%
Last update: Jun 17, 11:35 AM

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-33.45M
Investing Cash Flow (TTM)
-15.58M
Financing Cash Flow (TTM)
-3.81M
Free Cash Flow (TTM)
-33.64M
Capital Expenditure (TTM)
-187.00K
Net Change in Cash (TTM)
-52.84M

Analyst Trends and Forecast

1
Feb
1
Apr
2
May
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.2
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$665.52M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
64.27
PB Ratio (TTM)
-
Earnings Yield % (TTM)
-11.04%
Earnings Yield % (FWD)
-4.38%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
-$0.13

Company Debt

Total Debt
$24.58M
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-$633.00K
Total Cash
$8.06M
Debt to Equity
-
Issuance of Debt (TTM)
-$633.00K
Repayment of Debt (TTM)
-$40.36M

Key Statistics

Open
$10.05
Close
-
Volume / Avg.
15.04K / 343.97K
Day Range
$10.00 - $10.59
52 Wk Range
0.88 - 17.25
Market Cap
$663.30M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
45
Short Interest
5.51%
Days to Cover
20.97

About

Sector
Health Care
Industry
Biotechnology
Adlai Nortye Ltd is a clinical-stage company at the forefront of discovering and developing cancer therapies. The company is building a robust pipeline of drug candidates focused on two key areas where it believes it can make a difference RAS-targeti...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Adlai Nortye (ANL) stock?

A

You can purchase shares of Adlai Nortye (NASDAQ:ANL) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Adlai Nortye (ANL) competitors?

A

There are no as such competitors for Adlai Nortye.

Q

What is the forecast, or price target, for Adlai Nortye (ANL) stock?

A

Adlai Nortye has a consensus price target of $24.67.

Q

What is the current price for Adlai Nortye (ANL)?

A

The stock price for Adlai Nortye (NASDAQ: ANL) is $10.3 last updated June 17, 2026 at 11:35 AM EDT.

Q

Does Adlai Nortye (ANL) pay a dividend?

A

There are no upcoming dividends for Adlai Nortye.

Q

When is Adlai Nortye (NASDAQ:ANL) reporting earnings?

A

Adlai Nortye does not have any upcoming earnings scheduled.

Q

Is Adlai Nortye (ANL) going to split?

A

There is no upcoming split for Adlai Nortye.

Q

What sector and industry does Adlai Nortye (ANL) operate in?

A

Adlai Nortye is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.